BridgeMD
New treatment option for Breast Cancer
Official title Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
ClinicalTrials.gov ID: NCT04690439
What this study is testing
- What it's testing
- Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Diagnosed with breast cancer
- Underwent ipsilateral lumpectomy or mastectomy + sentinel lymph node biopsy +/- lymph node dissection
- Underwent radiotherapy with or without chemotherapy
- Diagnosed with BCRL (i.e. International Society of Lymphology (ISL) lymphedema stage I or higher)
- Age ≥ 18 years
You likely can't join if
- Metastatic disease
- Pregnancy
- History of surgery or trauma to the arm
- History of arm infection in the past 3 months
- Use of medications that affect body fluid (e.g., diuretics) in the last 3 months
- Severe psychological disorder or dementia
See the full eligibility criteria
- Diagnosed with breast cancer
- Underwent ipsilateral lumpectomy or mastectomy + sentinel lymph node biopsy +/- lymph node dissection
- Underwent radiotherapy with or without chemotherapy
- Diagnosed with BCRL (i.e. International Society of Lymphology (ISL) lymphedema stage I or higher)
- Age ≥ 18 years
- Able to comply to the study protocol
- Able to sign written informed consent
- Metastatic disease
- Pregnancy
- History of surgery or trauma to the arm
- History of arm infection in the past 3 months
- Use of medications that affect body fluid (e.g., diuretics) in the last 3 months
- Severe psychological disorder or dementia
- Any condition that is unstable or could affect the safety of the patient and their compliance in the study as judged by the investigator
The study team makes the final eligibility decision.
Where it's taking place
- Hasselt, Limburg, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hasselt, Limburg, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.